Post-Transplant Lymphoproliferative Disorder and other Malignancies after Liver Transplantation

Natasha Chandok, Kymberly D.S. Watt

Research output: Chapter in Book/Report/Conference proceedingChapter


Malignancy is a common cause of morbidity and mortality after liver transplantation. Liver transplant recipients have a number of unique risk factors that predispose them to cancer development. Several of these risk factors exist prior to the transplant itself, making it important for transplant physicians to be aware of these and to minimize the potential incremental risk after a transplant. After liver transplantation, patients should be counselled to reduce modifiable risk factors such as sun exposure, smoking, and alcohol intake. Strategies to minimize immunosuppression should also be considered. Once diagnosed with a malignancy after liver transplantation, the prognosis appears to be worse than for those diagnosed with the same malignancy in the general population. Transplant patients should be screened to prevent malignancy or malignancies should be diagnosed at the earliest possible stage.

Original languageEnglish (US)
Title of host publicationMedical Care of the Liver Transplant Patient
Subtitle of host publication4th Edition
Number of pages8
ISBN (Print)9781444335910
StatePublished - Mar 28 2012


  • Cancer
  • Immunosuppression
  • Liver transplant
  • Lymphoma
  • Malignancy
  • Post-transplant lymphoproliferative disorder
  • Risk factors

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Post-Transplant Lymphoproliferative Disorder and other Malignancies after Liver Transplantation'. Together they form a unique fingerprint.

Cite this